NeuroOne Medical Technologies Corporation
NMTC
$0.652
$0.04858.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 234.92% | -63.29% | 31.10% | 195.43% | -37.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 234.92% | -63.29% | 31.10% | 195.43% | -37.72% |
| Cost of Revenue | 14.80% | -46.52% | -23.67% | 5.58% | 29.83% |
| Gross Profit | 162.01% | 38.66% | 44.60% | 47.27% | -909.12% |
| SG&A Expenses | -5.98% | 16.80% | 1.00% | 9.98% | 30.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -64.22% | -20.93% | -12.57% | 7.60% | 30.23% |
| Operating Income | 150.47% | 11.00% | 20.41% | 17.44% | -90.01% |
| Income Before Tax | 153.37% | -6.87% | 20.22% | 18.95% | -93.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 153.37% | -6.87% | 20.22% | 18.95% | -93.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 153.37% | -6.87% | 20.22% | 18.95% | -93.03% |
| EBIT | 150.47% | 11.00% | 20.41% | 17.44% | -90.01% |
| EBITDA | 153.31% | 11.27% | 20.92% | 18.16% | -90.55% |
| EPS Basic | 141.54% | 20.17% | 48.71% | 48.65% | -30.52% |
| Normalized Basic EPS | 141.56% | 21.83% | 48.74% | 47.24% | -30.58% |
| EPS Diluted | 141.36% | 20.17% | 48.71% | 48.65% | -31.09% |
| Normalized Diluted EPS | 141.45% | 21.83% | 48.74% | 47.24% | -30.58% |
| Average Basic Shares Outstanding | 28.51% | 33.90% | 55.60% | 57.85% | 47.84% |
| Average Diluted Shares Outstanding | 28.69% | 33.90% | 55.60% | 57.85% | 47.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |